Alkermes (ALKS) News Today $27.91 +0.43 (+1.56%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Segall Bryant & Hamill LLC Trims Stock Holdings in Alkermes plc (NASDAQ:ALKS)Segall Bryant & Hamill LLC lowered its position in Alkermes plc (NASDAQ:ALKS - Free Report) by 3.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,183,100 shares of the company's stock after selling 37,November 20 at 6:48 AM | marketbeat.comRoyce & Associates LP Acquires 22,356 Shares of Alkermes plc (NASDAQ:ALKS)Royce & Associates LP grew its holdings in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 49.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 67,628 shares of the company's stock after acquiring an additional 22,356 shares during the period. Royce &November 20 at 3:59 AM | marketbeat.comAMG National Trust Bank Increases Stake in Alkermes plc (NASDAQ:ALKS)AMG National Trust Bank raised its holdings in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 68.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 59,645 shares of the company's stock after purNovember 19 at 5:12 AM | marketbeat.comAlkermes plc (NASDAQ:ALKS) Receives $35.42 Consensus PT from BrokeragesNovember 19 at 2:43 AM | americanbankingnews.comAlkermes plc (NASDAQ:ALKS) Given Consensus Rating of "Moderate Buy" by AnalystsAlkermes plc (NASDAQ:ALKS - Get Free Report) has earned a consensus rating of "Moderate Buy" from the twelve research firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and eight havNovember 16, 2024 | marketbeat.comAlkermes (NASDAQ:ALKS) Given New $40.00 Price Target at MizuhoMizuho boosted their target price on shares of Alkermes from $35.00 to $40.00 and gave the company an "outperform" rating in a research note on Wednesday.November 13, 2024 | marketbeat.comCraig C. Hopkinson Sells 58,996 Shares of Alkermes plc (NASDAQ:ALKS) StockNovember 13, 2024 | insidertrades.comPrincipal Financial Group Inc. Trims Stock Position in Alkermes plc (NASDAQ:ALKS)Principal Financial Group Inc. cut its position in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 7.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 877,943 shares of the company's stock after sellingNovember 13, 2024 | marketbeat.comAlkermes to Participate in Two Upcoming Investor ConferencesNovember 11, 2024 | prnewswire.comRobeco Institutional Asset Management B.V. Buys 45,857 Shares of Alkermes plc (NASDAQ:ALKS)Robeco Institutional Asset Management B.V. raised its position in Alkermes plc (NASDAQ:ALKS - Free Report) by 92.4% during the third quarter, according to its most recent filing with the SEC. The firm owned 95,509 shares of the company's stock after purchasing an additional 45,857 shares during theNovember 10, 2024 | marketbeat.comVan ECK Associates Corp Has $2.92 Million Holdings in Alkermes plc (NASDAQ:ALKS)Van ECK Associates Corp increased its stake in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 40.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 104,986 shares of the company'sNovember 10, 2024 | marketbeat.comInsider Selling: Alkermes plc (NASDAQ:ALKS) EVP Sells 10,471 Shares of StockNovember 7, 2024 | insidertrades.comAlkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific ConferencesNovember 7, 2024 | prnewswire.comStifel Upgrades Alkermes (ALKS)November 7, 2024 | msn.comAlkermes (NASDAQ:ALKS) Shares Gap Up - Time to Buy?Alkermes (NASDAQ:ALKS) Shares Gap Up - Here's What HappenedNovember 5, 2024 | marketbeat.comAlkermes raised to buy by Stifel on increased confidence for ALKS2680November 5, 2024 | msn.comAlkermes (NASDAQ:ALKS) Upgraded by Stifel Nicolaus to Buy RatingStifel Nicolaus raised Alkermes from a "hold" rating to a "buy" rating and upped their price target for the company from $25.00 to $36.00 in a report on Tuesday.November 5, 2024 | marketbeat.comAlkermes upgraded to Buy from Hold at StifelNovember 4, 2024 | markets.businessinsider.comStifel bullish on orexin, upgrades Alkermes to BuyNovember 4, 2024 | markets.businessinsider.comDekaBank Deutsche Girozentrale Lowers Stock Holdings in Alkermes plc (NASDAQ:ALKS)DekaBank Deutsche Girozentrale lessened its position in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 89.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,614 shares of the company's stock after sellNovember 4, 2024 | marketbeat.comAlkermes plc (NASDAQ:ALKS) Sees Significant Decrease in Short InterestAlkermes plc (NASDAQ:ALKS - Get Free Report) saw a significant decrease in short interest in the month of October. As of October 15th, there was short interest totalling 15,820,000 shares, a decrease of 7.9% from the September 30th total of 17,180,000 shares. Based on an average daily trading volume, of 1,720,000 shares, the short-interest ratio is presently 9.2 days.October 30, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Cuts Stake in Alkermes plc (NASDAQ:ALKS)Allspring Global Investments Holdings LLC reduced its stake in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 42.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 119,775 shares of the company's stock after selling 89,7October 29, 2024 | marketbeat.comAlkermes (ALKS) Gets a Hold from Stifel NicolausOctober 29, 2024 | markets.businessinsider.comAlkermes Inc.: Strong Q3 Performance and Strategic Growth Drive Buy RatingOctober 27, 2024 | markets.businessinsider.comAlkermes: Navigating Revenue Shifts and Investing in Orexin-2 Agonist Amidst Neutral Profit OutlookOctober 26, 2024 | markets.businessinsider.comAlkermes (ALKS) Gets a Hold from J.P. MorganOctober 26, 2024 | markets.businessinsider.comAlkermes' Q3 Proprietary Sales Soar 18%October 26, 2024 | fool.comAlkermes PLC (ALKS) Q3 2024 Earnings Call Highlights: Strong Proprietary Product Growth and ...October 26, 2024 | finance.yahoo.comAlkermes price target lowered to $30 from $32 at Goldman SachsOctober 26, 2024 | markets.businessinsider.comAlkermes (ALKS) Receives a New Rating from Cantor FitzgeraldOctober 26, 2024 | markets.businessinsider.comAlkermes (NASDAQ:ALKS) Given New $30.00 Price Target at The Goldman Sachs GroupThe Goldman Sachs Group dropped their target price on shares of Alkermes from $32.00 to $30.00 and set a "buy" rating for the company in a research note on Friday.October 25, 2024 | marketbeat.comAlkermes (NASDAQ:ALKS) Receives Overweight Rating from Piper SandlerPiper Sandler reissued an "overweight" rating and set a $37.00 target price (down previously from $38.00) on shares of Alkermes in a research report on Friday.October 25, 2024 | marketbeat.comAlkermes (NASDAQ:ALKS) Shares Gap Down - Should You Sell?Alkermes (NASDAQ:ALKS) Shares Gap Down - What's Next?October 24, 2024 | marketbeat.comMoody Aldrich Partners LLC Has $2.38 Million Stock Position in Alkermes plc (NASDAQ:ALKS)Moody Aldrich Partners LLC boosted its stake in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 36.8% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 84,907 shares of the company's stock after acquiringOctober 24, 2024 | marketbeat.comAlkermes (NASDAQ:ALKS) Issues FY 2024 Earnings GuidanceAlkermes (NASDAQ:ALKS) updated its FY 2024 earnings guidance. The company provided EPS guidance of 2.800-2.800 for the period, compared to the consensus estimate of 2.670. The company also issued revenue guidance of $1.5 billionillion-$1.6 billionillion, compared to the consensus estimate of $1.5 billionillion.October 24, 2024 | marketbeat.comAlkermes Plc Q3 Profit Increases, But Misses EstimatesOctober 24, 2024 | markets.businessinsider.comAlkermes plc Reports Third Quarter 2024 Financial ResultsOctober 24, 2024 | prnewswire.comAlkermes plc (NASDAQ:ALKS) Given Average Rating of "Moderate Buy" by AnalystsAlkermes plc (NASDAQ:ALKS - Get Free Report) has been given an average rating of "Moderate Buy" by the eleven ratings firms that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have givenOctober 22, 2024 | marketbeat.comVontobel Holding Ltd. Buys 31,687 Shares of Alkermes plc (NASDAQ:ALKS)Vontobel Holding Ltd. increased its position in Alkermes plc (NASDAQ:ALKS - Free Report) by 128.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 56,261 shares of the company's stock aftOctober 20, 2024 | marketbeat.comAlkermes (ALKS) to Release Quarterly Earnings on ThursdayAlkermes (NASDAQ:ALKS) will be releasing earnings before the market opens on Thursday, October 24, Zacks reports.October 18, 2024 | marketbeat.comLeerink Partnrs Brokers Cut Earnings Estimates for AlkermesAlkermes plc (NASDAQ:ALKS - Free Report) - Stock analysts at Leerink Partnrs decreased their FY2024 earnings per share estimates for Alkermes in a note issued to investors on Tuesday, October 15th. Leerink Partnrs analyst M. Goodman now expects that the company will earn $2.31 per share for the yOctober 18, 2024 | marketbeat.comExchange Traded Concepts LLC Sells 23,944 Shares of Alkermes plc (NASDAQ:ALKS)Exchange Traded Concepts LLC lowered its position in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 44.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 30,053 shares of the company's stock after seOctober 18, 2024 | marketbeat.comAlkermes to Report Third Quarter Financial Results on October 24, 2024October 17, 2024 | prnewswire.comAlkermes Public Limited CompanyOctober 16, 2024 | cnn.com20,399 Shares in Alkermes plc (NASDAQ:ALKS) Acquired by SG Americas Securities LLCSG Americas Securities LLC bought a new stake in Alkermes plc (NASDAQ:ALKS - Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 20,399 shares of the company's stock, valued at approximately $57October 15, 2024 | marketbeat.comAnalysts Conflicted on These Healthcare Names: Nurix Therapeutics (NRIX) and Alkermes (ALKS)October 14, 2024 | markets.businessinsider.comAssessing Alkermes’ ALKS-2680: A Hold Rating amidst Potential and Prudence in Sleep Disorder TreatmentOctober 14, 2024 | markets.businessinsider.comQ2 2025 EPS Estimates for Alkermes plc (NASDAQ:ALKS) Decreased by AnalystAlkermes plc (NASDAQ:ALKS - Free Report) - Investment analysts at Zacks Research lowered their Q2 2025 earnings per share estimates for shares of Alkermes in a research report issued to clients and investors on Wednesday, October 9th. Zacks Research analyst R. Department now forecasts that the coOctober 14, 2024 | marketbeat.comIs Alkermes (ALKS) The Most Undervalued Quality Stock To Buy According To Analysts?October 13, 2024 | msn.comZacks Research Analysts Increase Earnings Estimates for Alkermes plc (NASDAQ:ALKS)Alkermes plc (NASDAQ:ALKS - Free Report) - Analysts at Zacks Research boosted their Q1 2026 earnings per share (EPS) estimates for shares of Alkermes in a research note issued to investors on Wednesday, October 9th. Zacks Research analyst R. Department now expects that the company will post earniOctober 11, 2024 | marketbeat.com Get Alkermes News Delivered to You Automatically Sign up to receive the latest news and ratings for ALKS and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. ALKS Media Mentions By Week ALKS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALKS News Sentiment▼1.300.45▲Average Medical News Sentiment ALKS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALKS Articles This Week▼56▲ALKS Articles Average Week Get Alkermes News Delivered to You Automatically Sign up to receive the latest news and ratings for ALKS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Agios Pharmaceuticals News Pacira BioSciences News Atea Pharmaceuticals News ADC Therapeutics News Nektar Therapeutics News Seres Therapeutics News United Therapeutics News Incyte News Neurocrine Biosciences News BioMarin Pharmaceutical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALKS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alkermes plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Alkermes With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALKS Stock Alerts